RedShiftBio

Life sciences company developing Microfluidic Modulation Spectroscopy (MMS) technology to measure previously undetectable structural changes in biomolecules for biopharmaceutical development.

Location
Burlington, Massachusetts, USA
Founded
2015
Investors
1
Categories
biotech, biomolecules, structural-biology, analytical-technology

Investors

NameLocationTypeStagesPortfolio
Illumina VenturesSan Francisco, California, USAbiotech-focused
seedseries-a+1
32